Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has completed enrollment across …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Hepatoblastoma
• Hepatocellular Carcinoma
• Melanoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Dual checkpoint inhibitors (not disclosed)

Snippet

Sponsor: Children's National Research Institute | Conditions: Osteosarcoma, Ewing Sarcoma | Phase 2 | Status: COMPLETED